Trials / Completed
CompletedNCT01755091
Safety and Efficacy Study of Dronabinol to Treat Obstructive Sleep Apnea
Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- University of Illinois at Chicago · Academic / Other
- Sex
- All
- Age
- 21 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
This is a proof of concept study to determine the safety and efficacy of dronabinol for the treatment of obstructive sleep apnea syndrome (OSA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dronabinol | |
| DRUG | Placebo (for Dronabinol) |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2016-06-01
- Completion
- 2016-12-31
- First posted
- 2012-12-21
- Last updated
- 2021-07-29
- Results posted
- 2017-12-22
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01755091. Inclusion in this directory is not an endorsement.